Wolfe Research upgraded Tenet Healthcare to Outperform from Peer Perform with a $122 price target. The analyst sees upside to estimates from the Michigan supplemental Medicaid payment increase in 2024 coupled with the company’s deleveraging story. The firm confirmed that Michigan has increased its Provider Tax program by $2B for the state fiscal year 2024. Its analysis of state info and Tenet filings points to potential for a $150M to $200M benefit to the company’s bottom line or approximately 6%-8% upside versus Wolfe’s $2.64B 2024 EBITDA estimate.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet Healthcare price target raised to $110 from $100 at Mizuho
- Barclays starts health care facilities, managed care group with Neutral view
- Tenet Healthcare initiated with an Overweight at Barclays
- Tenet Healthcare Sells California Hospitals to Adventist Health
- Tenet Healthcare sells two hospitals, enters partnership with Adventist Heal
